PD-L1 drugs for Urothelial Carcinoma
2 tracked PD-L1 drugs in the Urothelial Carcinoma race. The class explanation lives on the PD-L1 page; the full indication pipeline across every mechanism is on the Urothelial Carcinoma page.
1 approved / phase 41 Phase 3